Allopurinol Tablets USP — Class II drug recall D-0168-2023
Terminated recall by Accord Healthcare, Inc., reported 2023-02-01, distributed nationwide. Presence of Foreign Substance: Presence of a small piece of green plastic embedded in the crack towards the ed
| Recall number | D-0168-2023 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Accord Healthcare, Inc., Durham, NC, United States |
| Recall initiated | 2023-01-12 |
| Classified | 2023-01-20 |
| Reported by FDA | 2023-02-01 |
| Terminated | 2024-04-23 |
| Distributed | Nationwide (US) |
| Quantity | 87,576 bottles |
| Reason classes | packaging |
| NDC | 16729-0134, 16729-0134-01, 16729-0134-10, 16729-0134-16, 16729-0134-17, 16729-0135, 16729-0135-01, 16729-0135-10, 16729-0135-16, 16729-0135-17 |
| Lot numbers | R2200455, R2200456 |
| Expiration dates | 2025-03 |
Product
Allopurinol Tablets USP, 100 mg, 100-count bottle, Rx Only, Manufactured for: Accord Healthcare, Inc., Durham, NC 27703, Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213. India. NDC 16729-134-01
Reason for recall
Presence of Foreign Substance: Presence of a small piece of green plastic embedded in the crack towards the edge of the tablet.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0168-2023. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.